Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free SXTPW Stock Alerts

60 Degrees Pharmaceuticals (SXTPW) Competitors

60 Degrees Pharmaceuticals logo
$0.03 +0.00 (+13.75%)
As of 07/24/2026 03:51 PM Eastern
Compare

SXTPW vs. DRTSW, APLMW, BIVIW, CDIOW, and CELUW

Should you buy 60 Degrees Pharmaceuticals stock or one of its competitors? MarketBeat compares 60 Degrees Pharmaceuticals with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with 60 Degrees Pharmaceuticals include Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), Cardio Diagnostics (CDIOW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

How does 60 Degrees Pharmaceuticals compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

In the previous week, Alpha Tau Medical had 2 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 4 mentions for Alpha Tau Medical and 2 mentions for 60 Degrees Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 0.93 beat Alpha Tau Medical's score of 0.40 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
60 Degrees Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

60 Degrees Pharmaceuticals beats Alpha Tau Medical on 2 of the 3 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Apollomics?

Apollomics (NASDAQ:APLMW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Apollomics. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat 60 Degrees Pharmaceuticals' score of 0.93 indicating that Apollomics is being referred to more favorably in the media.

Company Overall Sentiment
Apollomics Very Positive
60 Degrees Pharmaceuticals Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Summary

Apollomics beats 60 Degrees Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to BioVie?

BioVie (NASDAQ:BIVIW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

In the previous week, BioVie had 1 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 3 mentions for BioVie and 2 mentions for 60 Degrees Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 0.93 beat BioVie's score of 0.91 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BioVie
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
60 Degrees Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats BioVie on 2 of the 3 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Cardio Diagnostics?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals and 60 Degrees Pharmaceuticals both had 2 articles in the media. 60 Degrees Pharmaceuticals' average media sentiment score of 0.93 beat Cardio Diagnostics' score of 0.43 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Positive
Cardio Diagnostics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Cardio Diagnostics on 2 of the 2 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Celularity?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
Celularity$26.55MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Celularity N/A N/A N/A

In the previous week, Celularity had 1 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 3 mentions for Celularity and 2 mentions for 60 Degrees Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 0.93 beat Celularity's score of 0.22 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
60 Degrees Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Celularity
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Celularity beats 60 Degrees Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

Get 60 Degrees Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SXTPW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SXTPW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SXTPW vs. The Competition

Export
Metric60 Degrees PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$443.74M$7.06B$12.20B
Dividend YieldN/A3.91%2.67%9.41%
P/E RatioN/A3.4927.1423.63
Price / SalesN/A6,592.41582.30111.98
Price / CashN/A13.1349.8158.78
Price / BookN/A83.7010.286.01
Net IncomeN/A-$96.07M$3.60B$331.99M
7 Day PerformanceN/A-0.66%-1.27%-0.63%
1 Month PerformanceN/A-1.54%-1.67%-3.04%
1 Year PerformanceN/A55.33%18.25%13.30%

60 Degrees Pharmaceuticals Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
+13.8%		N/A-31.2%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$3.76
+0.3%		N/A+1,264.8%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.02
+2.1%		N/A-45.6%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.44
-0.5%		N/AN/A$0.00N/AN/AN/A
CDIOW
Cardio Diagnostics
N/A$0.02
flat		N/A-0.7%$0.00$16.57KN/A7

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SXTPW) was last updated on 7/26/2026 by MarketBeat.com Staff.
From Our Partners
The pact that ran the world and dollar just expired
In 1974, a U.S.-Saudi deal tied oil sales exclusively to dollars, forcing nations worldwide to hold dollars an...
Golden Portfolio | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Universal basic income is not impossible. It exist (kind of)
Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...
Freedom Financial | Sponsoredtc pixel
The invention Elon called the greatest in history
Jeff Brown and Marc Chaikin - two investors who called Nvidia a decade ago - say Elon Musk's newly filed AI pa...
Brownstone Research | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
They’re still buying the wrong AI stocks
Tesla and Alphabet just tumbled, and many investors concluded AI is over. It isn't - the easy AI trade may be....
The Oxford Club | Sponsoredtc pixel